368 filings
Page 6 of 19
DEFA14A
ATXI
Avenue Therapeutics Inc
17 Jan 23
Additional proxy soliciting materials
9:00am
SC 13D/A
ATXI
Avenue Therapeutics Inc
6 Jan 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
4:31pm
4
FBIO
Fortress Biotech Inc
4 Jan 23
Change in insider ownership
5:49pm
DEFA14A
ATXI
Avenue Therapeutics Inc
4 Jan 23
Additional proxy soliciting materials
11:01am
SC 13G
ATXI
Avenue Therapeutics Inc
4 Jan 23
AVENUE THERAPEUTICS / SABBY MANAGEMENT ownership change
8:25am
SC 13G/A
ATXI
Avenue Therapeutics Inc
14 Dec 22
AVENUE THERAPEUTICS / Nantahala Capital Management ownership change
4:06pm
DEFA14A
ATXI
Avenue Therapeutics Inc
18 Nov 22
Additional proxy soliciting materials
4:30pm
DEF 14A
ATXI
Avenue Therapeutics Inc
Definitive proxy
18 Nov 22
4:20pm
10-Q
2022 Q3
ATXI
Avenue Therapeutics Inc
Quarterly report
10 Nov 22
4:33pm
8-K
ATXI
Avenue Therapeutics Inc
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
PRE 14A
ATXI
Avenue Therapeutics Inc
Preliminary proxy
8 Nov 22
4:35pm
8-K
ATXI
Avenue Therapeutics Inc
8 Nov 22
Completion of Acquisition or Disposition of Assets
8:40am
8-K
ATXI
Avenue Therapeutics Inc
4 Nov 22
Departure of Directors or Certain Officers
4:25pm
SC 13D/A
InvaGen Pharmaceuticals, Inc.
19 Oct 22
AVENUE THERAPEUTICS / InvaGen Pharmaceuticals ownership change
7:26am
8-K
ATXI
Avenue Therapeutics Inc
18 Oct 22
Other Events
5:19pm
SC 13G
CVI Investments, Inc.
17 Oct 22
AVENUE THERAPEUTICS / CVI Investments ownership change
12:01pm
SC 13G
Intracoastal Capital, LLC
17 Oct 22
AVENUE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:01am
4
InvaGen Pharmaceuticals, Inc.
13 Oct 22
Change in insider ownership
8:52pm
8-K
ATXI
Avenue Therapeutics Inc
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
ATXI
Avenue Therapeutics Inc
11 Oct 22
Prospectus supplement with pricing info
8:27am